PTEN is frequently inactivated in various human cancers [11, 12, 19-21], and several studies have indicated that PTEN is frequently inactivated in gastric cancers due to genetic or epigenetic changes, such as mutation, loss of heterozygosity, promoter hypermethylation and regulation of microRNA [22-26]. This evidence concerns the gene PTEN and cancer.